Radioactive Tracer Market to exceed US$ US$ 14,675.73 million by 2030, says Premium Market Insights

The radioactive tracer market is expected to grow from $14,675.73 million in 2022 and is expected to reach to a value of US$ 54,296.57 million by 2030, it is anticipated to record a CAGR of 17.8% from 2022 to 2030.Radioactive Tracer Market Size and Forecast to 2030 - COVID-19 Impact and Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography

Get PDF Sample Report + All Related Table and Graphs @: https://www.premiummarketinsights.com/sample/TIP00073878?utm_source=OpenPR&utm_medium=10823

Competitive Landscape: Radioactive Tracer Market:
The driving factors include increasing prevalence of sleep apnea and growing demand for sleep apnea diagnostic devices and therapeutic solutions. However, low awareness of sleep apnea is hampering the radioactive tracer market growthMany market players and research institutes operating in the radioactive tracer market are developing advanced products to expand their product portfolios and increase their market shares. They invest significant amounts in R&D to develop advanced products. A few of the recent developments related to sleep apnea are mentioned below:In June 2021, IBA Launched Versatile High-Energy New Cyclotron, the Cyclone IKON, which offers the largest energy SPECT rum for PET and SPEC isotopes from 13 MeV to 30 MeV. IBA has redesigned its previous model, Cyclone 30 MeV, and created a next generation system, the Cyclone IKON. It is more compact and versatile than ever and is capable of working over a large energy span (13 to 30MeV) with full current capacity to enable the large-scale and high-purity production of emerging PET isotopes, SPECT isotopes and parent isotopes.

Rotem Industries Ltd
Abx Advanced Biochemical Compounds Gmbh
Invicro Llc
Cardinal Health Inc
Newcastle University
Novartis AG
Curium
Blue Earth Diagnostics Limited
General Electric Co
IBA Radiopharma Solutions
Bottom of Form

Chapter Details of Radioactive Tracer Market:
Part 01: Executive Summary
Part 02: Scope of The Report
Part 03: Radioactive Tracer Market Landscape
Part 04: Radioactive Tracer Market Sizing
Part 05: Radioactive Tracer Market Segmentation by Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis

Interested in Purchasing this Report? Click here @ https://www.premiummarketinsights.com/buy/TIP00073878?utm_source=OpenPR&utm_medium=10823

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sushant More
SE-mail: sales@permiummarketinsights.com
Phone: +1-646-491-9876

About Us:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.

This release was published on openPR.